Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel

ClinicalTrials.gov ID: NCT01665599

Public ClinicalTrials.gov record NCT01665599. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 7:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-label, Non-randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males

Study identification

NCT ID
NCT01665599
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
180 participants

Conditions and interventions

Interventions

  • Testosterone gel (FE 999303) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2012
Primary completion
Mar 31, 2013
Completion
Apr 30, 2013
Last update posted
Oct 25, 2017

2012 – 2013

United States locations

U.S. sites
17
U.S. states
14
U.S. cities
17
Facility City State ZIP Site status
Medical Affiliated Research Cente Huntsville Alabama
California Professional Research Newport Beach California
San Diego Sexual Medicine San Diego California
Connecticut Clinical Research Middlebury Connecticut
South Florida Medical Research Aventura Florida
Michigan Institute of Urology Saint Clair Shores Michigan
Quality Clinical Research Omaha Nebraska
Premier Urology Associates Lawrenceville New Jersey
University Urology New York New York
Premier Medical Group of the Hudson Valley Poughkeepsie New York
PMG Research of Wilmington Winston-Salem North Carolina
Tristate Urologic Services Cincinnati Ohio
Omega Medical Research Warwick Rhode Island
Coastal Carolina Research Center Mt. Pleasant South Carolina
Carolina Urologic Research Center Myrtle Beach South Carolina
Clinical Research Associates Nashville Tennessee
Urology Clinics of North Texas Dallas Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01665599, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2017 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01665599 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →